Story at-a-glance
Studies show a 45% increased risk of suicidal ideation in patients taking semaglutide (Ozempic/Wegovy) compared to other medications, with even higher risks for those with pre-existing mental health conditions Analysis of adverse event reports reveals higher rates of psychiatric issues, including depression, anxiety, and suicidal thoughts, associated with GLP-1 receptor agonist drugs used for weight loss Semaglutide may affect…
Read with caution - this story is only being covered by one news source that has a ‘low factuality’ rating, which means the outlet has a history of poor reporting practices. Learn more about factuality ratings here.